glp-1 epilepsy GLP-1s May Reduce Risk in Adults With Diabetes Could GLP-1 Drugs Lower Epilepsy

Diabetic Medicine, 28(6), 715723

Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)

Concerned about weight gain, diabetes risk, or metabolic health

Whether microdosing any GLP-1 agonist produces clinically meaningful results remains an open question in the research literature

Weight Loss Stocks Many investors may choose to invest in weight loss stocks of individual pharmaceutical companies developing weight loss drugs

Suboxone, a medication often used to treat opioid use disorder (OUD), has become a vital tool which offers a safer and more controlled approach to managing opioid addiction